← Evidence map

ArticleFrontiers in pharmacology2024

Risk of dyslipidemia and major adverse cardiac events with tofacitinib

Xiao-Na Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 38881871